Similar articles

• Immunologic reconstitution of patients with primary immunodeficiency diseases and cancer after treatment with thymosin.

  Goldstein AL, Thurman GB, Rossio JL, Costanzi JJ. Goldstein AL, et al. Transplant Proc. 1977 Mar;9(1):1141-4. Transplant Proc. 1977. PMID: 325742 No abstract available.
• Thymosin for immunodeficiency diseases and cancer.

  Goldstein AL, Rossio JL. Goldstein AL, et al. Compr Ther. 1978 Feb;4(2):49-57. Compr Ther. 1978. PMID: 624213 No abstract available.
• Thymosin treatment of children with primary immunodeficiency disease.

  Wara DW, Ammann AJ. Wara DW, et al. Transplant Proc. 1978 Mar;10(1):203-9. Transplant Proc. 1978. PMID: 305674 No abstract available.
• Thymosin: basic properties and clinical potential in the treatment of patients with immunodeficiency diseases and cancer.

  Goldstein AL. Goldstein AL. Antibiot Chemother (1971). 1978;24:47-59. doi: 10.1159/000401500. Antibiot Chemother (1971). 1978. PMID: 350140 Review. No abstract available.
• [Results and prospects of using thymosin for the purpose of regulating the immune system in different pathological processes and states].

  Grinevich IuA, Kamenets LIa. Grinevich IuA, et al. Zh Mikrobiol Epidemiol Immunobiol. 1979 Dec;(12):9-15. Zh Mikrobiol Epidemiol Immunobiol. 1979. PMID: 390944 Review. Russian. No abstract available.